AGENT FOR PREVENTING AND/OR TREATING MOVEMENT DISORDER
    1.
    发明申请
    AGENT FOR PREVENTING AND/OR TREATING MOVEMENT DISORDER 有权
    防止和/或治疗运动障碍的代理

    公开(公告)号:US20090105277A1

    公开(公告)日:2009-04-23

    申请号:US11916783

    申请日:2006-06-07

    IPC分类号: A61K31/496

    摘要: For example, an agent for preventing and/or treating movement disorder comprising, as an active ingredient, a triazolopyrimidine derivative having an adenosine A2A receptor antagonistic action, which is represented by the following formula (I): (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group, R2 represents a hydrogen atom, or the like, R3 represents —WR4, or the like, and Q1 represents a hydrogen atom or 3,4-dimethoxybenzyl), or a pharmaceutically acceptable salt thereof, and the like are provided.

    摘要翻译: 例如,作为活性成分,含有下述式(I)表示的腺苷A2A受体拮抗作用的三唑并嘧啶衍生物作为活性成分的预防和/或治疗运动障碍的药剂(其中,R1表示取代或未取代的芳基 或取代或未取代的杂环基,R2表示氢原子等,R3表示-WR4等,Q1表示氢原子或3,4-二甲氧基苄基)或其药学上可接受的盐, 喜欢被提供。

    Agent for preventing and/or treating movement disorder
    2.
    发明授权
    Agent for preventing and/or treating movement disorder 有权
    用于预防和/或治疗运动障碍的药剂

    公开(公告)号:US07851478B2

    公开(公告)日:2010-12-14

    申请号:US11916783

    申请日:2006-06-07

    IPC分类号: A61K31/505 C07D491/00

    摘要: For example, an agent for preventing and/or treating movement disorder comprising, as an active ingredient, a triazolopyrimidine derivative having an adenosine A2A receptor antagonistic action, which is represented by the following formula (I): (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group, R2 represents a hydrogen atom, or the like, R3 represents —WR4, or the like, and Q1 represents a hydrogen atom or 3,4-dimethoxybenzyl), or a pharmaceutically acceptable salt thereof, and the like are provided.

    摘要翻译: 例如,作为活性成分,含有下述式(I)表示的腺苷A2A受体拮抗作用的三唑并嘧啶衍生物作为活性成分的预防和/或治疗运动障碍的药剂(其中,R1表示取代或未取代的芳基 或取代或未取代的杂环基,R2表示氢原子等,R3表示-WR4等,Q1表示氢原子或3,4-二甲氧基苄基)或其药学上可接受的盐, 喜欢被提供。